NeoGenomics (United States)

NeoGenomics (United States)

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for NeoGenomics (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

53%


Total
Publications

405


Total Open
Publications

214


Total
Citations

6K


Open Access
Percentage

53%


Total
Publications

405


Total Open
Publications

214


Total
Citations

6K

Wikipedia

Website

download

Breakdown

23% 22% 8% 47%

Publisher Open

23%

Both

22%

Other Platform Open

8%

Closed

47%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

28%OA Journal

OA Journal 28%

50

Hybrid 25%

46

No Guarantees 47%

84

Other Platform Open

Domain 73%

90

Institution 34%

42

Preprint 20%

25

Other Internet 15%

19

Public 10%

12

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
90
Europe PMC
Domain
50
Figshare
Public
20
University of Edinburgh - Edinburgh Research Explorer
Institution
18
Research Square
Preprint
10
DOI
Other Internet
10
Semantic Scholar
Public
9
bioRxiv
Preprint
8
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
7
unl.edu OAI-PMH Repository
Institution
6
1 / 5

Data updated 17 June 2024

Share

Share

Share